{
    "id": "640c821c201352f04a000023",
    "question": "Is Wilson's disease described as an iron storage disease?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to analyze the characteristics of Wilson's disease and iron storage diseases. Wilson's disease is an autosomal recessive disorder that affects copper metabolism, leading to copper accumulation in the liver, brain, and other organs. It is caused by mutations in the ATP7B gene, which encodes a membrane-bound copper-transporting ATPase. The disease is characterized by liver disease, neuropsychiatric symptoms, and corneal changes due to copper deposition. On the other hand, iron storage diseases are characterized by excessive iron accumulation in the body, often leading to tissue damage and organ dysfunction. The main characteristics of iron storage diseases include hemochromatosis, hereditary hemochromatosis, and hemosiderosis. Given these characteristics, we can see that Wilson's disease is not primarily an iron storage disease, but rather a copper metabolism disorder. However, it is essential to note that Wilson's disease can lead to iron accumulation in the liver, which can be mistaken for an iron storage disease. Therefore, the correct answer is not a straightforward yes or no, but rather an understanding of the underlying pathophysiology. However, based on the primary characteristics of Wilson's disease, the answer is more inclined towards B.\", \"answer_choice\": \"B\"}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_29005",
            "title": "InternalMed_Harrison",
            "content": "Hemochromatosis Lawrie W. Powell DEFINITION Hemochromatosis is a common inherited disorder of iron metabolism in which dysregulation of intestinal iron absorption results in deposi-tion of excessive amounts of iron in parenchymal cells with eventual 428Endocrinology and Metabolism tissue damage and impaired function in a wide range of organs. The iron-storage pigment in tissues is called hemosiderin because it was believed to be derived from the blood. The term hemosiderosis is used to describe the presence of stainable iron in tissues, but tissue iron must be quantified to assess body-iron status accurately (see below and Chap. 126). Hemochromatosis refers to a group of genetic diseases that predispose to iron overload, potentially leading to fibrosis and organ failure. Cirrhosis of the liver, diabetes mellitus, arthritis, cardiomyopathy, and hypogonadotropic hypogonadism are the major clinical manifestations."
        },
        {
            "id": "Pathology_Robbins_301",
            "title": "Pathology_Robbins",
            "content": "Fig. 2.25 Lipofuscingranulesincardiacmyocytes(depositsindicatedbyarrows). ferritin micelles, readily visualized by light and electron microscopy; the iron can be unambiguously identified by the Prussian blue histochemical reaction ( Fig. 2.26 ). Although hemosiderin accumulation is usually pathologic, small amounts of this pigment are normal in the mononuclear phagocytes of the bone marrow, spleen, and liver, where aging red cells are normally degraded. Excessive deposition of hemosiderin, called hemosiderosis, and more extensive accumulations of iron seen in hereditary hemochromatosis are described in Chapter 16. Pathologic calcification, a common process in a wide variety of disease states, is the result of an abnormal deposition of calcium salts, together with smaller amounts of iron, magnesium, and other minerals. It can occur in two ways."
        },
        {
            "id": "Pediatrics_Nelson_2836",
            "title": "Pediatrics_Nelson",
            "content": "Wilson disease is characterized by abnormal storage of copper in the liver, leading to hepatocellular injury, CNS dysfunction, and hemolytic anemia. It is an autosomal recessive trait caused by mutations in the ATP7B gene. The encoded protein of this gene functions as an ATP-driven copper pump. The diagnosis is made by identifying depressed serum levels of ceruloplasmin, elevated 24-hour urine copper excretion, the presence of Kayser-Fleischer rings in the iris, evidence of hemolysis, and elevated hepatic copper content. In any single patient, one or more of these measures may be normal. Clinical presentation also varies, but seldom occurs before age 3 years. Neurologic abnormalities may predominate, including tremor, decline in school performance, worsening handwriting, and psychiatric disturbances. Anemia may be the first noted symptom. Hepatic presentations include appearance of jaundice, spider hemangiomas, portal hypertension and its consequences, and fulminant hepatic failure."
        },
        {
            "id": "Biochemistry_Lippincott_1403",
            "title": "Biochemistry_Lippinco",
            "content": "III. MICROMINERALS (TRACE MINERALS) The trace minerals include copper (Cu), iron (Fe), manganese (Mn), and zinc (Zn). They are required by adults in amounts between 1 and 100 mg/day. A. Copper Cu is a key component of several enzymes that play critical functions in the body (Fig. 29.5). These include ferroxidases such as the ceruloplasmin and hephaestin involved in the oxidation of ferrous iron (Fe2+) to the ferric form (Fe3+) that is required for its intracellular storage or transport through blood (see B.1. below). Meat, shellfish, nuts, and whole grains are good dietary sources of Cu. Dietary deficiency is uncommon. If a deficiency does develop, anemia may be seen because of the effect on Fe metabolism. Toxicity from dietary sources is rare (UL = 10 mg/day). Menkes syndrome and Wilson disease are genetic causes of Cu deficiency and Cu overload, respectively. 1."
        },
        {
            "id": "InternalMed_Harrison_5729",
            "title": "InternalMed_Harrison",
            "content": "Deficiency Dietary copper deficiency is relatively rare, although it has been described in premature infants who are fed milk diets and in infants with malabsorption (Table 96e-2). Copper-deficiency anemia (refractory to therapeutic iron) has been reported in patients with malabsorptive diseases and nephrotic syndrome and in patients treated for Wilson\u2019s disease with chronic high doses of oral zinc, which can interfere with copper absorption. Menkes kinky hair syndrome is an X-linked metabolic disturbance of copper metabolism characterized by mental retardation, hypocupremia, and decreased circulating ceruloplasmin (Chap. 427). This syndrome is caused by mutations in the copper-transporting ATP7A gene. Children with this disease often die within 5 years because of dissecting aneurysms or cardiac rupture. Aceruloplasminemia is a rare autosomal recessive disease characterized by tissue iron overload, mental deterioration, microcytic anemia, and low serum iron and copper concentrations."
        },
        {
            "id": "Neurology_Adams_7780",
            "title": "Neurology_Adams",
            "content": "Hereditary Deficiency of Ceruloplasmin (Aceruloplasminemia, CP Mutation) This is a rare illness, biochemically similar to Wilson disease, occurring in patients with a recessively inherited deficiency of ceruloplasmin; it is not simply a heterozygous form of Wilson disease (the mutation involves a different gene). Cirrhosis and Kayser-Fleischer rings are not features of the disease but diabetes is common and extrapyramidal signs may or may not arise. Rather than copper, iron is deposited in the brain and liver (see discussion by Logan). Those few cases that have been well studied, mainly Japanese, show mainly an ataxic disorder (Miyajima et al)."
        },
        {
            "id": "InternalMed_Harrison_29051",
            "title": "InternalMed_Harrison",
            "content": "A recent large population study has suggested that subjects homozygous for C282Y are at increased risk of breast and colorectal cancer. The HFE mutation is of northern European origin (Celtic or Nordic) with a heterozygous carrier rate of approximately 1 in 10 (1 in 8 in Ireland). Thus, HFE-associated hemochromatosis is quite rare in non-European populations, e.g., Asia. However, nonHFE-associated hemochromatosis resulting from mutations in other genes involved in iron metabolism (Fig. 428-1) is ubiquitous and should be considered when one encounters iron overload. wilson\u2019s Disease George J. Brewer Wilson\u2019s disease is an autosomal recessive disorder caused by muta-tions in the ATP7B gene, which encodes a membrane-bound, copper-transporting ATPase. Clinical manifestations are caused by copper toxicity and primarily involve the liver and the brain. Because effective 429 treatment is available, it is important to make this diagnosis early."
        },
        {
            "id": "InternalMed_Harrison_24086",
            "title": "InternalMed_Harrison",
            "content": "Wilson\u2019s Disease Wilson\u2019s disease is an inherited disorder of copper homeostasis first described in 1912 (Chap. 429). The Wilson\u2019s disease gene was discovered in 1993, with the identification of ATP7B. This P-type ATPase is involved in copper transport and is necessary for the export of copper from the hepatocyte. Thus, in patients with mutations in ATP7B, copper is retained in the liver, leading to increased copper storage and ultimately liver disease as a result."
        },
        {
            "id": "Biochemistry_Lippincott_1405",
            "title": "Biochemistry_Lippinco",
            "content": "Wilson disease: In Wilson disease, an autosomal-recessive (AR) disorder affecting 1:35,000 live births, efflux of excess Cu from the liver by ATP7B is impaired. Cu accumulates in the liver; leaks into the blood; and is deposited in the brain, eyes, kidneys, and skin. In contrast to Menkes syndrome, urinary and serum free Cu are high (see Fig. 29.6). Hepatic dysfunction and neurologic and psychiatric symptoms are seen. Kayser-Fleischer rings (corneal deposits of Cu) may be present (Fig. 29.7). Life-long use of Cu-chelating agents, such as penicillamine, is the treatment. The bioavailability (percent of the amount ingested that is able to be absorbed) of a mineral can be influenced by other minerals. For example, excess Zn decreases the absorption of Cu, and Cu is needed for the absorption of Fe. B. Iron"
        },
        {
            "id": "InternalMed_Harrison_23257",
            "title": "InternalMed_Harrison",
            "content": "Family history can be helpful in assessing liver disease. Familial causes of liver disease include Wilson\u2019s disease; hemochromatosis and \u03b11 antitrypsin deficiency; and the more uncommon inherited pediatric liver diseases\u2014i.e., familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis, and Alagille syndrome. Onset of severe liver disease in childhood or adolescence in conjunction with a family history of liver disease or neuropsychiatric disturbance should lead to investigation for Wilson\u2019s disease. A family history of cirrhosis, diabetes, or endocrine failure and the appearance of liver disease in adulthood suggests hemochromatosis and should prompt investigation of iron status. Abnormal iron studies in adult patients warrant genotyping of the HFE gene for the C282Y and H63D mutations typical of genetic hemochromatosis. In children and adolescents with iron overload, other non-HFE causes of hemochromatosis should be sought. A family history of emphysema should"
        },
        {
            "id": "InternalMed_Harrison_24087",
            "title": "InternalMed_Harrison",
            "content": "The clinical presentation of Wilson\u2019s disease is variable and includes chronic hepatitis, hepatic steatosis, and cirrhosis in adolescents and young adults. Neurologic manifestations indicate that liver disease is present and include speech disorders and various movement disorders. Diagnosis includes the demonstration of a reduced ceruloplasmin level, increased urinary excretion of copper, the presence of Kayser-Fleischer rings in the corneas of the eyes, and an elevated hepatic copper level, in the appropriate clinical setting. The genetic diagnosis of Wilson\u2019s disease is difficult because >500 mutations in ATP7B have been described with different degrees of frequency and penetration in certain populations. PART 14 Disorders of the Gastrointestinal System"
        },
        {
            "id": "Pathology_Robbins_2741",
            "title": "Pathology_Robbins",
            "content": "The normal total body iron mass is about 2.5 g for women and 3.5 g for men. Approximately 80% of functional body iron is present in hemoglobin, with the remainder located in myoglobin and iron-containing enzymes (e.g., catalase, cytochromes). The iron storage pool, consisting of hemosiderin and ferritin-bound iron in the liver, spleen, bone marrow, and skeletal muscle, contains on average 15% to 20% of total body iron. Because serum ferritin is largely derived from this storage pool, the serum ferritin level is a good measure of iron stores. Assessment of bone marrow iron is another reliable but more invasive method for estimating iron stores. Iron is transported in the plasma bound to the protein transferrin. In normal persons, transferrin is about 33% saturated with iron, yielding serum iron levels that average 120 \u00b5g/dL in men and 100 \u00b5g/dL in women. Thus, the normal total iron-binding capacity of serum is 300 to 350 \u00b5g/dL. http://ebooksmedicine.net"
        },
        {
            "id": "Pathology_Robbins_3965",
            "title": "Pathology_Robbins",
            "content": "The age at onset and the clinical presentation of Wilson disease are extremely variable. Symptoms usually appear between 6 and 40 years of age. Acute or chronic liver disease are common presenting features. Neuropsychiatric manifestations are the initial features in most of the remaining cases and stem from deposition of copper in the basal ganglia."
        },
        {
            "id": "Pathology_Robbins_2752",
            "title": "Pathology_Robbins",
            "content": "Clinical Features. As in anemia of iron deficiency, the serum iron levels usually are low in the anemia of chronic disease, and the red cells may be slightly hypochromic and microcytic. Unlike iron deficiency anemia, however, storage iron in the bone marrow and serum ferritin are increased and the total iron-binding capacity is reduced. Administration of erythropoietin and iron can improve the anemia, but only effective treatment of the underlying condition is curative. The two principal causes of megaloblastic anemia are folate deficiency and vitamin B12 deficiency. Both vitamins are required for DNA synthesis and the effects of their deficiency on hematopoiesis are essentially identical. However, the causes and consequences of folate and vitamin B12 deficiency differ in important ways. We will first review some of the common features and then touch on those that are specific to folate and vitamin B12 deficiency."
        },
        {
            "id": "Pathology_Robbins_3953",
            "title": "Pathology_Robbins",
            "content": "severe with others, childhood. Whatever the underlying cause, the onset of disease typically occurs after 20 gm of stored iron have accumu lated. Excessive iron appears to be directly toxic to host tissues. Mechanisms of liver injury include the following:"
        },
        {
            "id": "InternalMed_Harrison_24021",
            "title": "InternalMed_Harrison",
            "content": "Wilson\u2019s disease is an inherited disorder of copper homeostasis with failure to excrete excess amounts of copper, leading to an accumulation in the liver. This disorder is relatively uncommon, affecting 1 in 30,000 individuals. Wilson\u2019s disease typically affects adolescents and young adults. Prompt diagnosis before end-stage manifestations become irreversible can lead to significant clinical improvement. Diagnosis requires determination of ceruloplasmin levels, which are low; 24-h urine copper levels, which are elevated; typical physical examination findings, including Kayser-Fleischer corneal rings; and characteristic liver biopsy findings. Treatment consists of copper-chelating medications."
        },
        {
            "id": "InternalMed_Harrison_29035",
            "title": "InternalMed_Harrison",
            "content": "Each of these methods for assessing iron stores has advantages and limitations. The serum iron level and percent saturation of transferrin are elevated early in the course, but their specificity is reduced by significant false-positive and false-negative rates. For example, serum iron concentration may be increased in patients with alcoholic liver disease without iron overload; in this situation, however, the hepatic 2517 iron index is usually not increased as in hemochromatosis (Table 428-1). In otherwise healthy persons, a fasting serum transferrin saturation greater than 45% is abnormal and suggests homozygosity for hemochromatosis."
        },
        {
            "id": "InternalMed_Harrison_29058",
            "title": "InternalMed_Harrison",
            "content": "Diagnostic tests for Wilson\u2019s disease are listed in Table 429-1. Serum ceruloplasmin levels should not be used for definitive diagnosis, because they are normal in up to 10% of affected patients and are reduced in 20% of carriers. Kayser-Fleischer rings (Fig. 429-1) can be definitively diagnosed only by an ophthalmologist using a slit lamp. They are present in >99% of patients with neurologic/psychiatric forms of the disease and have been described very rarely in the absence of Wilson\u2019s disease. Kayser-Fleischer rings are present in only \u223c30\u201350% of patients diagnosed in the hepatic or presymptomatic state; thus, the absence of rings does not exclude the diagnosis."
        },
        {
            "id": "InternalMed_Harrison_30465",
            "title": "InternalMed_Harrison",
            "content": "Wilson\u2019s disease (WD) is an autosomal recessive inherited disorder of copper metabolism that may manifest with neurologic, psychiatric, and liver disorders, alone or in combination. It is caused by mutations in the gene encoding a P-type ATPase. The disease was first comprehensively described by the English neurologist Kinnier Wilson at the beginning of the twentieth century, although at around the same time the German physicians Kayser and Fleischer separately noted the characteristic association of corneal pigmentation with hepatic and neurologic features. WD has a worldwide prevalence of approximately 1 in 30,000, with a gene carrier frequency of 1 in 90. About half of WD patients (especially younger patients) manifest with liver abnormalities. The remainder present with neurologic disease (with or without underlying liver abnormalities), and a small proportion have hematologic or psychiatric problems at disease onset."
        },
        {
            "id": "InternalMed_Harrison_29034",
            "title": "InternalMed_Harrison",
            "content": "The degree of increase in total body iron stores can be assessed by (1) measurement of serum iron and the percent saturation of transferrin (or the unsaturated iron-binding capacity), (2) measurement of serum ferritin concentration, (3) liver biopsy with measurement of the iron concentration and calculation of the hepatic iron index (Table 428-2), and (4) magnetic resonance imaging (MRI) of the liver. In addition, a retrospective assessment of body-iron storage is also provided by performing weekly phlebotomy and calculating the amount of iron removed before iron stores are exhausted (1 mL blood = approximately 0.5 mg iron)."
        },
        {
            "id": "Neurology_Adams_7784",
            "title": "Neurology_Adams",
            "content": "Reduced levels of PANK2 in the blood corroborate the diagnosis but this test is available only in research laboratories with an interest in the disease. The characteristic deposits of iron in the basal ganglia have not been associated with a demonstrable abnormality of serum iron or of iron metabolism. It has, however, been reported that there is increased uptake of radioactive iron in the region of the basal ganglia following intravenous injection of labeled ferrous citrate (Vakili et al; Szanto and Gallyas). CT reveals hypodense zones in the lenticular nuclei, resembling those of hepatolenticular degeneration (also of sulfite oxidase deficiency, glutaric acidemia and Leigh disease), although high-density lesions have been described in one autopsy-proven case of this disease (Tennison et al). The MRI findings are striking (Fig. 36-8). In T2-weighted images, the rim of the pallidum appears intensely black (iron deposition), with a small white area in its medial part that represents a"
        },
        {
            "id": "First_Aid_Step1_421",
            "title": "First_Aid_Step1",
            "content": "Treatment: chelation with penicillamine or trientine, oral zinc. Liver transplant in acute liver failure related to Wilson disease. Autosomal recessive. On HFE gene, located on chromosome 6; associated with HLA-A3. Leads to abnormal iron sensing and \u008f intestinal absorption (\u008f ferritin, \u008f iron, \u0090 TIBC \u008e\u008f transferrin saturation). Iron overload can also be 2\u00b0 to chronic transfusion therapy (eg, \u03b2-thalassemia major). Iron accumulates, especially in liver, pancreas, skin, heart, pituitary, joints. Hemosiderin (iron) can be identified on liver MRI or biopsy with Prussian blue stain A ."
        },
        {
            "id": "InternalMed_Harrison_7983",
            "title": "InternalMed_Harrison",
            "content": "Evaluation of Bone Marrow Iron Stores Although RE iron stores can be estimated from the iron stain of a bone marrow aspirate or biopsy, the measurement of serum ferritin has largely supplanted these procedures for determination of storage iron (Table 126-3). The serum ferritin level is a better indicator of iron overload than the marrow iron stain. However, in addition to storage iron, the marrow iron stain provides information about the effective delivery of iron to developing erythroblasts. Normally, when the marrow smear is stained for iron, 20\u201340% of developing erythroblasts\u2014called sideroblasts\u2014will have visible ferritin granules in their cytoplasm. This represents iron in excess of that needed for hemoglobin synthesis. In states in which release of iron from storage sites is blocked, RE iron will be detectable, and there will be few or no sideroblasts. In the myelodysplastic syndromes, mitochondrial dysfunction can occur, and accumulation of iron in mitochondria appears in a"
        },
        {
            "id": "Histology_Ross_2958",
            "title": "Histology_Ross",
            "content": "In addition, the liver functions in the storage, meta bolism, and homeostasis of iron. It synthesizes almost all of the proteins involved in iron transport and metabolism, including transferrin, haptoglobin, and hemopexin. Transferrin is a plasma iron-transport protein. Haptoglobin binds to free hemoglobin in the plasma, from which the entire complex is removed by the liver to preserve iron. Hemopexin is involved in the transport of free heme in the blood. Iron is stored within the hepatocyte cytoplasm in the form of ferritin or may be converted to hemosiderin granules. Recent studies indicate that hepatocytes are the major sites of long-term storage of iron. Iron overload (as in multiple blood transfusions) may lead to hemochromatosis, a form of liver damage characterized by excessive amounts of hemosiderin in hepatocytes. The liver degrades drugs and toxins. Hepatocytes are involved in degradation of drugs, toxins, and other proteins foreign to the body (xenobiotics)."
        },
        {
            "id": "InternalMed_Harrison_29020",
            "title": "InternalMed_Harrison",
            "content": "(yrs.) Cirrhosis, organ failure Progressive tissue injury Increased total body iron Increased hepatic iron Increased serum iron Increased iron absorption FIGURE 428-2 Sequence of events in genetic hemochromatosis and their correlation with the serum ferritin concentration. Increased iron absorption is present throughout life. Overt, symptomatic disease usually develops between ages 40 and 60, but latent disease can be detected long before this. and 5to 25-fold in the heart. Iron deposition in the pituitary causes hypogonadotropic hypogonadism in both men and women. Tissue injury may result from disruption of iron-laden lysosomes, from lipid peroxidation of subcellular organelles by excess iron, or from stimulation of collagen synthesis by activated stellate cells."
        },
        {
            "id": "Biochemistry_Lippincott_1427",
            "title": "Biochemistry_Lippinco",
            "content": "Correct answer = H. The patient has Wilson disease, an autosomal-recessive disorder that decreases copper efflux from the liver because of mutations to the hepatic copper transport protein ATP7B. Some copper leaks into the blood and is deposited in the brain, eyes, kidney, and skin. This results in liver and kidney damage, neurologic effects, and corneal changes caused by the excess copper. Administration of the metal chelator penicillamine is the treatment. [Note: Because zinc is also chelated, supplementation with zinc is common.] Graves disease results in hyperthyroidism. Hereditary hemochromatosis is a disorder of iron overload. Keshan disease is the result of selenium deficiency, whereas selenosis is caused by selenium excess. Menkes syndrome is the result of a systemic deficiency in copper as a result of mutations to ATP7A, an intestinal copper transport protein."
        },
        {
            "id": "Pathoma_Husain_103",
            "title": "Pathoma_Husain",
            "content": "B. Most common type of anemia 1. Lack of iron is the most common nutritional deficiency in the world, affecting roughly 1/3 of world's population. C. Iron is consumed in heme (meat-derived) and non-heme (vegetable-derived) forms. 1. Absorption occurs in the duodenum. Enterocytes have heme and non-heme (DMTl) transporters; the heme form is more readily absorbed. 2. Enterocytes transport iron across the cell membrane into blood via ferroportin. 3. Transferrin transports iron in the blood and delivers it to liver and bone marrow macrophages for storage. 4. Stored intracellular iron is bound to ferritin, which prevents iron from forming free radicals via the Fenton reaction. pathoma.com D. Laboratory measurements of iron status 1. Serum iron-measure of iron in the blood 2. Total iron-binding capacity (TIBC)-measure of transferrin molecules in the blood 3. % saturation-percentage of transferrin molecules that are bound by iron (normal is 33%) 4."
        },
        {
            "id": "InternalMed_Harrison_24079",
            "title": "InternalMed_Harrison",
            "content": "Figure 366e-30 Wilson\u2019s disease showing extensive hepatocyte cytoplasmic red granular staining for copper in a cirrhotic nodule (rhodanine copper stain, 20\u00d7). Genetic, Metabolic, and Infiltrative Diseases Affecting the Liver Bruce R. Bacon There are a number of disorders of the liver that fit within the 367e categories of genetic, metabolic, and infiltrative disorders (Table 367e-1). Inherited disorders include hemochromatosis, Wilson\u2019s disease, \u03b11 antitrypsin (\u03b11AT) deficiency, and cystic fibrosis (CF). Hemochromatosis is the most common inherited disorder affecting white populations, with the genetic susceptibility for the disease being identified in 1 in 250 individuals. Over the past 15 years, it has become increasingly apparent that nonalcoholic fatty liver disease (NAFLD) is the most common cause of elevated liver enzymes found in the U.S. population. This disorder is discussed in greater detail in Chap. 364. Infiltrative disorders of the liver are relatively rare."
        },
        {
            "id": "InternalMed_Harrison_22685",
            "title": "InternalMed_Harrison",
            "content": "Disorders of Absorption Henry J. Binder Disorders of absorption constitute a broad spectrum of conditions with multiple etiologies and varied clinical manifestations. Almost all of these clinical problems are associated with diminished intestinal absorption of one or more dietary nutrients and are often referred to as the malabsorption syndrome. This term is not ideal as it represents a pathophysiologic state, does not provide an etiologic explanation for the underlying problem, and should not be considered an adequate final diagnosis. The only clinical conditions in which absorption is increased are hemochromatosis and Wilson\u2019s disease, in which absorption of iron and copper, respectively, is elevated."
        },
        {
            "id": "Immunology_Janeway_1380",
            "title": "Immunology_Janeway",
            "content": "tract and acts in iron metabolism by regulating the uptake of dietary iron into the body. It seems to interact with the transferrin receptor and decrease the receptor\u2019s affinity for iron-loaded transferrin. Individuals defective for this gene have an iron-storage disease, hereditary hemochromatosis, in which an abnormally high level of iron is retained in the liver and other organs. Mice lacking \u03b22-microglobulin have defective expression of all class I molecules and thus also show a similar iron overload. Another MHC gene with a nonimmune function encodes the enzyme 21-hydroxylase, which, when deficient, causes congenital adrenal hyperplasia and, in severe cases, salt-wasting syndrome. Even where a disease-related gene is clearly homologous to immune-system genes, as is the case with HFE, the disease mechanism may not be immune-related. Disease associations mapping to the MHC must therefore be interpreted with caution, in the light of a detailed understanding of its genetic structure"
        },
        {
            "id": "InternalMed_Harrison_29048",
            "title": "InternalMed_Harrison",
            "content": "The importance of family screening and early diagnosis and treatment cannot be overemphasized. Asymptomatic individuals detected by family studies should have phlebotomy therapy if iron stores are moderately to severely increased. Assessment of iron stores at appropriate intervals is also important. With this management approach, most manifestations of the disease can be prevented."
        },
        {
            "id": "InternalMed_Harrison_7973",
            "title": "InternalMed_Harrison",
            "content": "The progression to iron deficiency can be divided into three stages (Fig. 126-2). The first stage is negative iron balance, in which the demands for (or losses of) iron exceed the body\u2019s ability to absorb iron from the diet. This stage results from a number of physiologic mechanisms, including blood loss, pregnancy (in which the demands for red cell production by the fetus outstrip the mother\u2019s ability to provide iron), rapid growth spurts in the adolescent, or inadequate dietary iron intake. Blood loss in excess of 10\u201320 mL of red cells per day is greater than the amount of iron that the gut can absorb from a normal diet. Under these circumstances, the iron deficit must be made up by mobilization of iron from RE storage sites. During this period, iron stores\u2014reflected by the serum ferritin level or the appearance of stain-able iron on bone marrow aspirations\u2014decrease. As long as iron stores are present and can be mobilized, the serum iron, total iron-binding capacity (TIBC), and red"
        }
    ],
    "scores": [
        0.03267386557507216,
        0.029132295119882815,
        0.028781367200667395,
        0.028059667979713668,
        0.027835110652448113,
        0.02760010514325769,
        0.027396323448955026,
        0.026853749355642047,
        0.026445432541948817,
        0.026200899371631083,
        0.02599550509998271,
        0.024750104157440122,
        0.02469885427084244,
        0.023966921119592872,
        0.02395060127073593,
        0.02356632344033919,
        0.023370248349409227,
        0.022908572908572906,
        0.02261589533230756,
        0.022311455737099604,
        0.022240661833274434,
        0.022134820139580944,
        0.02202969520042691,
        0.021804672211350292,
        0.021687390912726444,
        0.02160194503514879,
        0.021554506099960645,
        0.021479937467430953,
        0.021327673230359983,
        0.020862235147949434,
        0.02020760067167253,
        0.018672160753608717
    ]
}